SCHEMBL235139

SCHEMBL235139

C=C(C)C(=O)OCCC(c1ccccc1)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 2/20 0.49
MTNR1B P49286 2/20 0.49
POLB P06746 1/20 0.47
APEX1 P27695 1/20 0.47
HTT P42858 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
CHRNB2 P17787 1/20 0.45
CHRNB4 P30926 1/20 0.45
CHRNA3 P32297 1/20 0.45
CHRNA4 P43681 1/20 0.45
THRB P10828 1/20 0.44
TSHR P16473 3/20 0.43
HPGD P15428 1/20 0.43
CACNA1B Q00975 1/20 0.42
KMT2A Q03164 1/20 0.42
CHRM2 P08172 2/20 0.41
CHRM4 P08173 2/20 0.41
CHRM1 P11229 2/20 0.41
CHRM3 P20309 2/20 0.41
ELANE P08246 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15901492 0.92 TDP1 (0.50) MTNR1AMTNR1BPOLBAPEX1HTT
SCHEMBL13801021 0.89 HPGD (0.44) POLBAPEX1HTTTDP1CHRNB2
SCHEMBL28037217 0.87 POLB (0.43) MTNR1AMTNR1BPOLBAPEX1HTT
SCHEMBL14192622 0.86 THRB (0.42) POLBAPEX1HTTTDP1CHRNB2
SCHEMBL27371666 0.86 POLB (0.42) MTNR1AMTNR1BPOLBAPEX1HTT
SCHEMBL5184279 0.85 CHRM1 (0.42) MTNR1AMTNR1BPOLBAPEX1HTT
SCHEMBL21837195 0.85 CHRNB2 (0.68) POLBAPEX1HTTTDP1CHRNB2
Hydrochloric Acid SCHEMBL2691425 0.85 CHRM1 (0.42) MTNR1AMTNR1BPOLBAPEX1HTT
SCHEMBL28328831 0.85 POLB (0.44) POLBAPEX1HTTTDP1CHRNB2
SCHEMBL3180135 0.84 TSHR (0.53) MTNR1AMTNR1BPOLBAPEX1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 185 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1444239-B1 HIGH REFRACTIVE INDEX AROMATIC-BASED SILYL MONOMERS BAUSCH & LOMB (US) 2008-12-24 EP claimed
EP-1448571-B1 HIGH REFRACTIVE INDEX AROMATIC-BASED SILOXANE MONOFUNCTIONAL MACROMONOMERS BAUSCH & LOMB (US) 2008-05-21 EP claimed
US-7169874-B2 High refractive index polymeric siloxysilane compositions BAUSCH & LOMB INCORPORATED (US) 2007-01-30 US claimed
US-6908978-B2 High refractive index polymeric siloxysilane compositions BAUSCH & LOMB INCORPORATED (US) 2005-06-21 US claimed
US-20050085611-A1 High refractive index aromatic-based siloxane difunctional macromonomers BAUSCH & LOMB MEXICO, S.A. DE C.V. (MX) 2005-04-21 US claimed
EP-1519968-A1 LOW WATER CONTENT HIGH REFRACTIVE INDEX, FLEXIBLE, POLYMERIC COMPOSITIONS BAUSCH & LOMB INCORPORATED (US) 2005-04-06 EP claimed
US-6852793-B2 Low water content, high refractive index, flexible, polymeric compositions BAUSCH & LOMB INCORPORATED (US) 2005-02-08 US claimed
US-20040230023-A1 High refractive index aromatic-based silyl monomers SALAMONE JOSEPH C (US) 2004-11-18 US claimed
US-20040215156-A1 High refractive index aromatic-based silyl monomers SOLTA MEDICAL, INC. 2004-10-28 US claimed
US-20040215032-A1 High refractive index aromatic-based silyl monomers SALAMONE JOSEPH C 2004-10-28 US claimed
US-20030144451-A1 High refractive index aromatic-based siloxane difunctional macromonomers BAUSCH HEALTH US, LLC 2003-07-31 US claimed
US-20030139557-A1 High refractive index aromatic-based siloxane monofunctional macromonomers PRECISION DERMATOLOGY, INC. 2003-07-24 US claimed
US-20030109661-A1 High refractive index polymeric siloxysilane compositions BAUSCH HEALTH US, LLC 2003-06-12 US claimed
US-20030105255-A1 High refractive index aromatic-based silyl monomers BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC. (CA) 2003-06-05 US claimed
US-20030100697-A1 High refractive index polymeric siloxysilane compositions SALIX PHARMACEUTICALS, INC. 2003-05-29 US claimed
WO-2003040154-A1 HIGH REFRACTIVE INDEX AROMATIC-BASED SILOXANE DIFUNCTIONAL MACROMONOMERS BAUSCH & LOMB INCORPORATED (US) 2003-05-15 WO claimed
WO-2003040158-A1 HIGH REFRACTIVE INDEX POLYMERIC SILOXYSILANE COMPOSITIONS BAUSCH & LOMB INCORPORATED (US) 2003-05-15 WO claimed
WO-2003040152-A1 HIGH REFRACTIVE INDEX AROMATIC-BASED SILYL MONOMERS BAUSCH & LOMB INCORPORATED (US) 2003-05-15 WO claimed
WO-2003040157-A1 HIGH REFRACTIVE INDEX POLYMERIC SILOXYSILANE COMPOSITIONS BAUSCH & LOMB INCORPORATED (US) 2003-05-15 WO claimed
WO-2003040155-A1 HIGH REFRACTIVE INDEX AROMATIC-BASED SILOXANE MONOFUNCTIONAL MACROMONOMERS BAUSCH & LOMB INCORPORATED (US) 2003-05-15 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040215032-A1 High refractive index aromatic-based silyl monomers SMAD2, SMAD3, FHIT MTNR1A 4002/4885MTNR1B 4648/4885POLB 4487/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.